Background/Aims: To study the in vitro antibacterial activity of methanolic leaf extract of Combretum albidum in combination with the antibiotic ceftriaxone (CE) against multidrug-resistant (MDR) Pseudomonas aeruginosa, and to assess the host toxicity of the leaf extract with human cord blood-derived lymphocytes in vitro. Methods: The synergistic/antagonistic action of the leaf extract with CE was evaluated with the checkerboard procedure. The leaf extract and the antibiotic were added into the wells of a microtiter plate in serially proportionate combinations along with nutrient broth, bacterial inocula, and 2,3,5-triphenyltetrazolium chloride to achieve visible growth of the bacterium. Lymphocytes from human cord blood were cultured and the toxicity of the leaf extract was assessed by both acridine orange/ethidium bromide (AO/EB) staining method and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The test results were analyzed by the probit method. Results: Minimum inhibitory concentration (MIC) values of the methanolic leaf extract and CE separately were 0.866 and 0.0384 mg/mL, respectively. The MIC value of the leaf extract with the antibiotic was in the range of 0.102e0.866 mg/mL. Synergistic results in the in vitro control were obtained in all combinations of the antibiotic and the extract (i.e., from 9:1 to 5:5); ratios 1:9, 2:8, and 3:7 caused antagonism, whereas an indifference was seen at the ratio 4:6. Individual minimum bactericidal concentration (MBC) values of the leaf extract and CE were 4.39 and 87.7 mg/mL, respectively, whereas those of all combinations, 9:1 to 1:9, ranged from 0.33 to 3.07 mg/mL. The MBC value of the leaf extract alone was 4.39 mg/mL, whereas in various combinations with CE (at ratios from 9:1 to 1:9), the value varied from 0.70 to 3.07 mg/mL. The MBC value of CE was only 0.877 mg/mL in all combinations with the leaf extract. The plant extract level of 58.88 mg/mL was considered the lethal concentration 25 (LC 25 ) because of its lethal effects on lymphocytes, whereas the LC 25 value for CE was 380.19 mg/mL according to the AO/EB staining method. In the MTT assay, however, the LC 25 value of leaf extract was 53.70 mg/mL. Therefore, we used a leaf extract concentration of 50 mg/mL, which was a little below the LC 25 value of leaf extract obtained in the MTT assay (i.e., 53.70 mg/mL). Conclusion: This study provided the result of synergistic activity of the combination of crude leaf extract of C. albidum with CE against MDR P. aeruginosa. The leaf extract was nontoxic to human lymphocytes.
Introduction
Combination therapy, that is, the combined use of two or more drugs/antibiotics has been a popular method for controlling infectious diseases. In general, this kind of therapy has been recommended for the treatment of an active infection to achieve higher efficacy at comparatively lower level of each antimicrobial agent. The method has exquisitely been followed for the control of tuberculosis. 1 Obviously, combination therapy has been applauded amply and embroiled in the effective control module for the prevention of an infection after a surgical episode, at levels far below their individual host-toxicity levels to prevent the emergence of intriguing multidrug-resistant (MDR) pathogenic bacterial strains. 2, 3 Indeed, drugs/antibiotics used in combination therapy involve interactions that could be antagonistic, indifferent/ additive, or synergistic. Antagonism is defined as a scenario in which a combination of drugs is less effective than the single agents on a target organism. An example of such a situation could be an interaction of one or two bacteriostatic drugs, such as a protein synthesis inhibitor, chloramphenicol, or tetracycline, with penicillin or/and an aminoglycoside. 4 Obviously, while using multiple drugs/antibiotics in a therapy, better outcomes are achieved with fewer encumbrances. Indifferent/ additive effect is a combined action equivalent to the sum of actions of individual drugs used. 5 Synergism is a situation in which the combined effect is significantly or inimitably better than the sum of individual effects of the drugs used, 6 which is unequivocally desired in antimicrobial stewardship programs. Nowadays, there is more focus on the search for effective/new antimicrobials because of the recent need to control MDR pathogenic bacteria. 7 Plant-based antimicrobial drugs are widely investigated and they remain as potential sources of antimicrobials for the control of both bacteria and fungi. Indeed, the search for complementary and alternate therapeutics becomes an obsessive quest, and phytodrugs remain an exploitable and readily available source for the in vitro control of a series of MDR pathogens, which are repeatedly controlled with crude phytodrugs. 12e14 Because phytocompounds in crude plant extracts have inherently unbreachable barriers of complexity and are of nonmicrobial origin, no MDR microbes, including those with unique genetic makeups, could ever override these coalesced chemicals. If scaled up in a module, accessorized with the formal antimicrobial stewardship program, phytocompounds of suitable plants could be used as complementary and alternate medicines, rather than integrative medicines, such as mixing allopathic/mainstream and herbal medicines.
15e19 Basic information on herbal drugs is obtained from folklore literature of different cultures worldwide. By contrast, many antibiotics that became a routine against one or the other class of pathogen with a proven exquisite control capacity cannot ordinarily be replaced by a newer drug because of its recent failure in controlling an affronting MDR pathogen, nor the rising mortality rates can be assumed to be arising out of treatment failures. Moreover, an antibiotic at a specified dose that has been won over by a strain of a bacterium may control the resistant strain, when used at a higher dose. However, the same antibiotic at a comparatively higher dose would be toxic to the host organism. Thus, the most sought after blithesome situation would be the use of a new agent having a synergistic effect with a moribund antibiotic.
The in vitro interaction of two control agents could be monitored with a checkerboard and the time killer method alternately. 20 The former method involves the determination of percentage growth inhibition of the targeted bacterium in vitro in the presence of two drugs at different combinations. This is a simple method and the results can be easily interpreted. 23 causing infections at the urinary and respiratory tracts as well as at surgical/burn sites. Most of its strains were resistant to 30 mg/disc ceftriaxone (CE), which is the recommended dose in therapy. However, higher doses of CE would probably be effective in the control of P. aeruginosa, but at the same time could trigger many side effects, including diarrhea, nausea, vomiting, stomatitis, glossitis, hemolytic anemia, thrombocytopenia, exanthema, allergic dermatitis, pruritus, urticaria, and edema, etc. 24 Furthermore, leaves of the medicinal plant Combretum albidum G. Don are used in treating patients with jaundice and its bark is used for treating various skin diseases. 25 A decoction of the fruit is used for treating dysentery and diarrhoea. 26 Thus, C. albidum has an established record of ethnobotanical image, without any known host toxicity. Its bark extract also has liver-protective effects. 27 In this study, the interaction between the methanolic leaf extract of C. albidum and CE (a third-generation cephalosporin), which was ineffective at the recommended concentration against a great proportion of an MDR strain of P. aeruginosa isolated from clinical samples, had been monitored with the checkerboard method. The results obtained provide a rational base for the use of methanolic leaf extract of C. albidum, which is used by an aborigine tribe (the Kandha) of the local subtropical forest, and the moribund antibiotic CE (often used in empirical therapy for at least the control of respiratory ailments and untoward suppurations) in different combinations of each control agent against a CEresistant P. aeruginosa strain, which is resistant to several other antibiotics concomitantly in vitro, with the hope of achieving a desirable synergistic effect.
Logistically, monitoring host toxicity of the used antimicrobial agent is an essential corollary, regardless of its sourcedmicrobial or botanical or synthetic. Indeed, the host toxicity is monitored with experimental animals, which involves many tedious procedures. By contrast, stem cells/ lymphocytes from the umbilical cord blood (UCB) could be grown in vitro and used for testing the host toxicity. Obviously, the use of whole animal for testing host toxicity would be the ultimate practice before the use of a compound as a drug in humans. The use of cultured human cells is not an ordinary substitute, as it would give a chance for ascertaining the real situation of toxicity more correctly instead of using small experimental animals, such as mice; nonetheless, mammals are used as test animals. It is anticipated that the work with lymphocytes, especially from the human UCB, has neither the linked problems of involvement of trials with animals nor is an ethically sensitive issue, as it is a waste blood. Using lymphocytes in a toxicity study would serve as a suitable mirror of events in the human body. The host toxicity in this case is monitored using cultured lymphocytes, which are obtained from human cord blood and this study gives a comparative account of toxicity levels of the antibiotic CE as well as the crude leaf extract of the medicinal plant C. albidum.
Materials and methods

Preparations of plant extracts
Leaves of C. albidum G. Don (Family: Combretaceae) were dried at 37 C for 24 hours in an incubator and were further shade dried for 15 days. Dried leaves were powdered and the powdered mass was stored in air-tight polythene packs until further use. The methanolic extraction of leaves was carried out in a Soxhlet apparatus by mixing a series of 40 g of powdered mass with 400 mL of methanol for 24 hours; about 40 extracted units were obtained. After filtration, the extract was concentrated in a rotary evaporator. The sticky mass obtained was dried in a desiccator and a black solid mass was obtained, which was stored in a suitable volume of 10% dimethyl sulfoxide (DMSO) at the concentration of 50 mg/mL at 4 C until use. The yield of the solid mass was determined as 7.92%.
Screening of phytochemicals
The methanolic leaf extract was subjected to different tests in preliminary screening protocols for 17 active phytochemical constituents.
28e30 Qualitative phytochemical analyses of the plant extract for nine phytochemicals, namely, alkaloids, flavonoids, saponins, resins, steroids, tannins, glycosides, reducing sugars, and anthraquinones, were performed as described previously. 13 The additional eight phytochemicalsdphlobatannins, sterols, lipids/fats, acidic compounds, terpenoids, phenols, carbohydrates, and catecholdwere tested as follows:
Phlobatannins: A few drops of 1% HCl were added to the mixture of 0.5 g leaf extract in a tube with water in boiling state. The mixture was allowed to stand for the development of a red precipitate, which confirms the presence of phlobatannins. Sterols (LiebermanneBurchard test): A lot of 0.5 g leaf extract was dissolved in an aliquot of 3.0 mL chloroform and a few drops of acetic anhydride were added along with a few drops of concentrated sulfuric acid (H 2 SO 4 ) along the sides of the test tube. Formation of a blue to blood red color confirms sterol. Lipids/fats: A small quantity of the powdered leaf extract was rubbed onto a filter paper. Appearance of a permanent translucent strain confirms lipids/fats. Acidic compounds: To a little amount of the extract, an aliquot of 1 mL of 4% sodium bicarbonate solution was added for effervescence to confirm the presence of acidic compounds.
Terpenoids (Salkowski's test): To a lot of 0.5 g of the extract, an aliquot of 2 mL of chloroform was added, followed by an addition of concentrated H 2 SO 4 (3 mL) to form a layer. A reddish brown color formation at the interface was noted, which confirms the presence of terpenoids. Phenols: A little amount of the extract was diluted with water to which an aliquot of 2 mL of 1% ferric chloride solution was added for the formation of green or blue color, which confirms the presence of phenol. Carbohydrates (Molisch's test): A small quantity of the extract was dissolved in an aliquot of 5 mL of distilled water and filtered. To this filtrate, two to three drops of anaphthol were added. In addition, an aliquot of 1 mL of concentrated H 2 SO 4 was added; two layers were formed with a violet-colored ring at the interface, which confirms the presence of carbohydrates. Catechol: To 2 g of the extract, 2 mL of freshly prepared Ehrlich's reagent was added along with a few drops of concentrated HCl. Formation of a black precipitate confirms the presence of catechol.
Isolation and identification of the bacterium
Strains of P. aeruginosa were isolated from clinical samples. Urine samples from patients with urinary tract infections were cultured on nutrient agar, for 18e24 hours, for the isolation of bacterial strains. Nonlactose fermenting, colorless colonies on MacConkey agar that also formed green-pigmented colonies on further streaking on nutrient agar (HiMedia, Mumbai, India) were tested for P. aeruginosa. These green-pigmented colonies inhibited the growth of other bacteria around them, and were confirmed as Gram-negative bacilli. P. aeruginosa were identified with specific biochemical tests. To confirm that P. aeruginosa colonies are obtained only from clinical samples and not from any nosocomial infection/contamination, many clinical samples were repeatedly plated. Isolated cells of P. aeruginosa were slender, noncapsulated with a polar flagellum. Confirmatory biochemical tests carried out included the catalase test, the oxidase test, and the growth of colonies in King's media, as described previously. 14, 23 The colonies were positive for oxidase, catalase, citrate, urease, and nitrate tests, whereas they were negative for indole, methyl red, and VogeseProskauer tests. When the colonies were further grown in King's B agar medium, fluorescein (pyoverdine) imparting a yellow tinge to the culture was observed and the colored material was insoluble in chloroform but soluble in water; some colonies developed bright red and water-soluble pyorubin. No pyomelanin, a brown to black pigment, was seen in any of the King's media. These tests confirmed the isolation of strains of P. aeruginosa. 23 
Antibiotic-sensitivity pattern of isolated P. aeruginosa
The disc diffusion method was used for the antibioticsensitivity test, using a 4-mm-thick MuellereHinton agar (MHA) medium, as explained previously. 23, 31 Fifty-one strains of P. aeruginosa were obtained and each strain was subjected to antibiotic-sensitivity test, using 17 antibiotics belonging to five groups, and one of the MDR strains that was resistant to CE 30 mg/disc was used for further study.
Determination of MIC and minimum bactericidal concentration values of the leaf extract and CE
A powdered form (injectable) of the antibiotic CE was dissolved in an appropriate volume of water to prepare a stock solution of 1 mg/mL. The concentration of the plant extract was 50 mg/mL. The sensitivities of P. aeruginosa to the methanolic leaf extract and CE were evaluated by determining the MIC values. Serial dilutions of the methanolic extract were added in succession to wells on a row in a 96-well (12 Â 8) microtiter plate (Fig. 1 ). An 80 mL aliquot of the leaf extract was added to the first well with a 100 mL aliquot of nutrient broth (HiMedia). From the first well, an aliquot of 80 mL was drawn and transferred to the second well containing 100 mL of nutrient broth. The remaining wells received 80 mL content of the previous well, in succession for the total of 11 wells; an aliquot of 20 mL bacterial inoculum (10 6 CFU/mL) and 5 mL aliquot of 0.5% of 2,3,5-triphenyltetrazolium chloride (TTC) were added to each well. The l2 th well did not receive the plant extract and served as the control. After adding all of the aforementioned constituents to each well, the microtiter plate was incubated at 37 C for 18 hours. A pink coloration owing to the presence of TTC in a well indicated bacterial growth and the absence of pink coloration was taken as growth inhibition. 13 The MIC (the lowest toxic concentration) value was noted at the well with the lowest level, in which the pink color was not manifested. 32 Further, bacterial content from each well of the microtiter plate was subcultured on nutrient agar plates; from previously ascertained MIC levels and above, the level of dilution, with which no bacterial growth on the nutrient agar plate was observed, was noted as the minimum bactericidal concentration (MBC) value (Fig. 2 ). This method was repeated to determine the MIC and MBC values of the antibiotic.
Checkerboard technique for combination activity of leaf extract and CE
To evaluate the synergistic/antagonistic interaction of the leaf extract with CE, the checkerboard procedure was used. 33 In this method, the leaf extract and the antibiotic were added into the wells of the microtiter plate (Fig. 1) in serially proportionate combinations along with nutrient broth, bacterial (an MDR strain) inocula, and TTC for the visible growth of the bacterium. The combinations of leaf extract and CE were prepared in the following proportions: 10:0, 9:1, 8:2, 7:3, 6:4, 5:5, 4:6, 3:7, 2:8, 1:9, and 0:10. Each proportion was adjusted to 1.0 mL in an Eppendorf tube. The solution in each tube was serially dispensed to a row of 11 wells in the microtiter plate. Finally, each well had an aliquot of 100 mL of nutrient broth, 20 mL aliquot of bacterial inoculum, and 5 mL aliquot of TTC, for the growth of the bacterium. The combinations were checked for MIC and MBC values with the antibiotic, as described earlier. Interaction was assessed algebraically by determining the FIC indices (FIC index ¼ FIC of extract þ FIC of CE). In addition, fractional bactericidal concentration (FBC) indices for both the leaf extract and the antibiotic were computed. The FIC index was interpreted as (1) a synergistic effect, when it was lesser than 0.5; (2) an additive or indifferent effect, when it was more than 0.5 and lesser than 1; and (3) an antagonistic effect, when it was more than 1.0. 
Inhibition zone of different concentrations of leaf extract of C. albidum
The inhibition zone (IZ) of the methanolic leaf extract of C. albidum against P. aeruginosa was determined by the agar cup method. 35 Inocula from an overnight nutrient broth culture of P. aeruginosa were firmly seeded over the MHA plates. The scooped out wells on agar plates were sealed by pouring 50-mL molten MHA. Aliquots of 100 mL leaf extract in twofold decreasing concentrations were poured into the wells of the plate. The plates were incubated at 37 C for 24 hours and the sizes of IZs around the wells were noted.
Separation of lymphocytes from cord blood
UCB was collected in a sterile 50-mL falcon tube (Tarsons, Kolkata, India) containing 500 mL of 1000 IU heparin (HiMedia). The UCB that was collected immediately after the delivery of an infant, and the blood sample (50 mL) was stored at 4 C until use. Lymphocytes were isolated immediately or within 24 hours after the collection. For the isolation of lymphocytes, the collected UCB sample was diluted with an equal volume of phosphate-buffered saline (PBS) solution. The mixture was carefully loaded for overlayering into a centrifuge tube with lymphocyte separating medium (LSM; HiMedia), which was one-third the total volume of the mixture. The total mixture was then centrifuged at 1800g for 25 minutes at 22e24 C. The buffy coat with mononuclear cells was carefully removed from the tube with layers. The layers (heavy to light) obtained are red blood cell, LSM, buffy coat, and plasma (Fig. 3) . The cells of the buffy coat layer, after dilution with another aliquot of PBS at the 1:1 ratio, were recentrifuged at 2000g for 5 minutes. The lymphocytes pellets were used for culturing, and the cell counts were measured using a hemocytometer.
Growth of lymphocytes and assessment of toxicity by staining method
The UCB-derived lymphocytes were diluted to the density of 1 Â 10 6 cells/mL with a required volume of Dulbecco's modified Eagle's medium with low glucose (HiMedia), and were loaded into a six-well culture plate (Tarsons), which contained 15% fetal bovine serum (Sigma, Taufkirchen, Germany), 1% penicillinestreptomycin, and 1% sodium pyruvate, along with different concentrations of methanolic extract (50, 25, 12.5, 6.25, and 3.125 mg/mL) of C. albidum leaves with 10% DMSO solution and different concentrations (1000, 500, 250, 125, 62.5, and 31.25 mg/mL) of CE, for the growth of UCB-derived lymphocytes. The stock solution of the C. albidum leaf extract was prepared by dissolving 50 mg of sticky methanolic leaf extract of the plant in a 1 mL aliquot of 10% DMSO solution, and the stock solution was stored at 4 C for further use; the total volume of 2 mL was maintained for each well of the culture plate with leaf extract. The cells were incubated with different concentrations of the leaf extract (50, 25, 12.5, 6.25, 3.125, and 0 mg/mL) at 37 C under 5% atmospheric CO 2 concentration for 24 hours. Their viability was investigated using the acridine orange/ethidium bromide (AO/EB) staining under a fluorescent microscope (Magnus, Noida, New Delhi, India). The AO/EB solution was prepared in PBS at the concentration of 100 mg/mL. Green color indicated live cells, whereas cells with orange and red color were apoptotic and necrotic cells, respectively (Fig. 4) . Toxicity values were obtained with concentrations of 50, 25, 12.5, 6.25, 3.125, and 0 mg/mL methanolic leaf extract, after 24 hours of incubation.
Percentages of lethality values of the third repeated experiment were converted to probit values (Finney's method), which were plotted against the corresponding log 10 values of methanolic leaf extract and CE concentrations, as described previously. 36 The probit values of the observed lethality percentages are from statistical tables of probit transformations. 37 2.10. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay Yellow 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), a tetrazole, is reduced to purple formazan in the mitochondria of living cells. The solution is quantified by measuring its absorbance at a wavelength between 500 and 600 nm using a spectrophotometer. The absorption maximum is dependent on the solvent used. This reduction takes place only when enzymes such as mitochondrial reductase are active, and therefore, the conversion can be directly related to the number of viable/living cells. The amount of purple formazan crystals produced by the cells treated with a toxin is low as compared with the amount of formazan crystals produced by the control cells.
The cell toxicities of both leaf extract and CE were assessed with the MTT assay; a stock of 5 mg/mL concentration of MTT solution was prepared with PBS. After 24 hours of methanolic leaf extract/antibiotic treatment to lymphocytes in a six-well culture plate, 80 mL of MTT solution was added to each well to study the toxic effect of each. The plate was further kept in an incubator (37 C, 5% CO 2 ) for 4 hours. It was found that the media containing lymphocytes and leaf extract/antibiotic manifested blue color due to the formation of formazan crystals. After 4 hours of incubation, the mixture was gently centrifuged at 1000g for 10 minutes at 22 C. The supernatant was discarded and the pellet was dissolved in an aliquot of 1 mL of 100% DMSO solution and the mixture was incubated at 37 C for 1 hour. The blue color becomes purple, after which the optical density at the 570 nm was measured using a spectrophotometer. Percentage of cell density is calculated as 100 Â (OD sample e OD blank )/OD control ; MTT in the DMSO solution was the blank. Probits of the observed lethality percentage values were used for analysis of toxicity.
Results
Interaction of plant extract with P. aeruginosa
Antibiotic-sensitivity test of 51 strains was performed. The levels of resistance percentages were more than 50% in nine of the 17 antibiotics tested, which clearly indicate the infection dynamics of P. aeruginosa in community sectors and nosocomial settings. Among the isolated strains, 96% strains were CE resistant, and the least level of resistance was observed with imipenem, a carbapenem. Of them, the strain used in further interactions with the leaf extract was resistant to CE (30 mg/disc), which was also resistant to amikacin, cefoperazone, ceftazidime, ciprofloxacin, gatifloxacin, gentamicin, levofloxacin, netillin, ofloxacin, piperacillin, and tobramycin; by contrast, the strain was sensitive to aztreonam, cefepime, cefoperazone/sulbactam, and piperacillin/tazobactam at specific levels, except for imipenem ( Table 1 ). The IZ sizes were measured from the highest (5000 mg/mL) to the lowest concentration (9.76 mg/mL) of the leaf extract against P. aeruginosa. The maximum IZ size recorded was 19.7 mm, and the minimum recorded size was 8.7 mm (Table 2) . A regression line was drawn with a log 10 value of different concentrations and the corresponding IZ square values. The line had a slope of y ¼ 121.6x e 73.3 and the Pearsonian correlation coefficient (r) of 0.9867 (Fig. 5) . As can be noted from the linear relationship between these two parameters and the high value of r, the leaf extract had a direct cause-and-effect relationship with the IZ sizes, due to 10 successive levels of twofold concentrations of the leaf extract and CE in the combination proportions used (Table 3) . In this study, the leaf extract level of 50 mg/mL was used in combination with CE (30 mg/disc) to control the growth of P. aeruginosa in vitro. The MIC value of the leaf extract was 0.866 mg/mL at the combination proportion of 10:0 and that of CE was 0.0384 mg/mL at the proportion of 0:10 (leaf extract:CE). The MIC value of the leaf extract was 0.102e0.866 mg/mL when combined with the antibiotic in all proportions (10:0 to 0:10), and the FIC index was 0.118e0.697 in all the cited proportions. An initial synergism was evident with higher proportions of the leaf extract with lower proportions of CE up to the 5:5 ratio, and the later antagonism was too evident at reverse ratios, 3:7 to 1:9; but the ratio 6:4 was indifferent (leaf extract:CE; Table 3 ). Individual MBC values of the leaf extract and CE were 4.39 mg/mL and 87.7 mg/mL, respectively, whereas those of combinations of all ratios (10:0, 9:1, 8:2, 7:3, 6:4, 5:5, 4:6, 3:7, 2:8, 1:9, and 0:10) ranged from 0.33 to 3.07 mg/mL; the FBC value of the leaf extract ranged from 0.08 to 0.70 (Table 4 ). The MBC value of C. albidum was 4.39 mg/mL when treated alone against the P. aeruginosa, whereas in different combinations (9:1 to 1:9) with CE, the values varied from 0.70 to 3.07 mg/mL. In the same way, when CE was treated alone with P. aeruginosa, the MBC value was 0.877 mg/mL. However, when CE was combined with different proportions of the leaf extract, the MBC values varied from 0.00172 to 0.1777 mg/mL in different combinations. The highest MBC value of the leaf extract in combination with CE was 3.07 mg/mL at the ratio 7:3 (leaf extract:CE), whereas at the ratio of 4:6, the MBC value was the lowest (0.33 mg/mL). The highest MBC value of CE was at the ratio of 1:9 and the lowest was at the ratio of 9:1. The FBC values of CE ranged from 0.04 to 2.03, at all ratios from 9:1 to 1:9 ( Table 4 ). The methanolic leaf extract had saponins, resins, steroids, tannins, glycosides, acidic compounds terpenoids, reducing sugars, phenols, carbohydrates, sterols, flavonoids, carotenoids, and alkaloids in qualitative phytochemical analyses, but phlobatannins, lipids or fats, acidic compounds, and anthraquinones were absent (Table 5) . Table 6 were used in the ordinate and log 10 values of plant extract concentrations in the abscissa for the construction of the plot (Fig. 6) , from which it was ascertained that for values of lethal concentration 25 (LC 25 ), the corresponding log 10 concentration value was 1.77. Antilog values of the obtained log 10 concentration value were 58.88 mg/mL, which is regarded as the LC 25 value of the leaf extract against human lymphocytes.
CE
By contrast, the treatment of cells with different concentrations of CE for 24 hours of incubation with lymphocytes resulted in a larger extent of decreasing pattern of living cell counts compared with that of the leaf extract. The number of dead cells increased upon increasing the concentration of CE from 62.5 to 1000 mg/mL. Using probit values (Table 7) , the probit plot was constructed (Fig. 6) , from which it was ascertained that values of LC 25 and LC 50 corresponding to Terpenoids þ "þ" means presence; "e" means absence. Log 10 values of concentrations of leaf extract and probits of observed percent lethality of cell death are plotted in Fig. 6 . The cells/mL values are average hemocytometric cell counts multiplied with average cell number Â 16 Â 2500 Â 2, with respect to 0 mg/mL leaf extract or 0 mg/mL ceftriaxone (3 replicates). AO/EB ¼ acridine orange/ethidium bromide. log 10 concentration values were 2.58 and 2.87, respectively. Antilog values of these log 10 concentration values were 380.19 and 741.3 mg/mL, respectively, which were the required LC 25 and LC 50 values of the CE against lymphocytes.
Host-toxicity testing with lymphocytes from human cord blood monitored by the MTT assay
In the MTT assay, the LC 25 value of the leaf extract was 53.70 mg/mL and the LC 50 value could not be determined from the probit plot (Fig. 7) , as levels higher than 50 mg/mL of the extract were not used in the combination with CE.
Further, the LC 25 and LC 50 values of CE were 154.88 and 602.56 mg/mL, respectively. Experimentally, the MIC values were 3.125 mg/mL of leaf extract and 62.5 mg/mL of CE. The Highest permissive concentration (HPC) and LC 100 values could not be determined for both leaf extract and CE, as these were considerably higher doses and were not used in the synergy/antagonistic interaction as well as with lymphocytes. Probit plots after probit conversions of percentage lethality values and log 10 values of leaf extract and CE concentrations were constructed (Fig. 7) . Thus, the level of 50 mg/mL leaf extract was a little below the LC 25 value of leaf extract, 53.70 mg/mL, compared to the MIC value, 3.125 mg/mL. The recommended value of CE (i.e., 30 mg/mL) was far less than its MIC valued62.5 with lymphocytesdduring the MTT assay. Histograms of LC values of lymphocytes treated with the AO/EB staining method and MTT assay in toxicity studies using leaf extract of C. albidum and CE are shown in Fig. 8 .
Discussion
The study results showed that the methanolic leaf extract of C. albidum alone at the minimum level (0.866 mg/mL) had a promising antipseudomonad activity against MDR isolates of the bacterium MDR P. aeruginosa, whose infectious activities were well presented in our hospital. 23 Further, it was seen that the leaf extract at the minimum level (0.866 mg/mL) had a potential effect on the enhancement of the activity of CE at the 0.0389 mg/mL level. The combination of leaf extract and the antibiotic had a synergistic effect with combination ratios from 9:1 to 5:5; especially, at the ratio of 7:3 (leaf extract:CE), the highest level of synergism, as found in three repeated experiments, was noticed. The combination ratio of 4:6 had an indifferent response and the remaining combinations with decreased levels of leaf extract (with increased levels of antibiotics) had an antagonistic effect against P. aeruginosa. The FIC indices were from 0.312 to 2.535. The individual MIC values were 0.102e0.604 mg/mL for C. albidum, and 0.00076e0.07897 mg/mL for CE. These results of in vitro Log 10 values of plant extract concentrations and probits of observed percentage lethality are plotted in Fig. 7 . The OD 570 values of the MTT assay were used for computing percent lethal values with respect to 0 mg/mL leaf extract or 0 mg/mL ceftriaxone (3 replicates).
MTT ¼ 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; OD 570 ¼ optical density at a wavelength of 570 nm. tests clearly indicated that the combination of the leaf extract and CE at particular ratios had a possible clinical significance. The best synergistic effect was obtained at the combination ratio 5:5, whereas at the ratio 4:6 an indifference was noticed, and at three successive lower levels, 3:7 to 1:9, antagonism was recorded. This signifies the importance of the leaf extract in combinational proportions in this study. At higher levels of the leaf extract in combinations, that is, from 9:1 to 6:4, there was a limited antibiotic dosage to be energized by the leaf extract in the combined application, as there were higher FIC indices. This clearly indicated that the plant extract had a synergistic effect with the action of the antibiotic CE. The spectrum of chemical constituents of C. albidum is such a diverse mixture that MDR P. aeruginosa should not overcome the leaf extract, as expected. The antibiotic CE was found to control the bacterial growth in higher doses in vitro, and therefore, it could be used at higher doses in vivo. However, many side effects are possible when the antibiotic is used at higher doses. Furthermore, host toxicity due to crude phytoextracts is also documented. 38 Therefore, the study of toxicity using animal models remains to be an essential corollary. However, this work epitomizes that even when a lower level of a moribund antibiotic is administered in combination with a moderate dose of the leaf extract of C. albidum, a nontoxic plant known from ethnobotanical reports, 25 the MDR pathogen can be controlled by avoiding various nontarget side effects of the antibiotic that would arise due to its use in higher doses. This conclusion is substantiated by nontoxic levels of the leaf extract on human lymphocytes, that is, the LC 25 values were obtained in the study.
Usually, for the control of P. aeruginosa, the combination therapy involves the use of a b-lactam and an aminoglycoside or a chloroquinol. 39 In literature, in vitro synergy rates for aztreonam (a b-lactam) combined with a fluoroquinolone against Gram-negative bacteria are available, but those are not comparable here, because of the variation in the microbial test method. 40 However, the combination of a leaf extract and the antibiotic provided a larger spectrum of antimicrobial effect on MDR P. aeruginosa, which should concomitantly prevent the emergence of MDR pathogens. Combinational drugs are often recommended for the control of pathogens and to have greater efficacy in the treatment of infection, if an attack of resistant tubercle bacillus mutants has not been confirmed. 1 Studies on combined applications of a plant extract and an antibiotic are rare in literature. 22, 41, 42 In vitro combined effects of erythromycin and the methanolic leaf extract of the plant Euphorbia hirta against the clinically isolated Gram-positive bacterium Staphylococcus aureus were described using the checkerboard technique. The MIC value of the plant extract alone was 25 mg/mL and that of the antibiotic alone was 0.005 mg/mL; however, when used in combination (9:1, 8:2, 7:3, 6:4, 3:7, 2:8, and 1:9) the extract and the drug had a synergistic effect. However, indifference was recorded at 5:5 and 4:6 combinations. 41 Further, in vitro synergistic actions of four essential oils of plants individually, Aniba rosaeodora, Melaleuca alternifolia, Origanum vulgare, and Pelargonium graveolens, had been described with the antibiotic gentamicin against Acinetobacter baumannii and 14 strains of Gram-positive and Gram-negative bacteria, with an FIC index of 0.11 using the checkerboard dilution method, 42 as done here. In another study, synergism between the antibiotic ampicillin and the methanolic extract of lichen Ramalina farinacea against clinical isolates of S. aureus was demonstrated at combination ratios of 9:1, 8:2, 6:4, 5:5, 4:6, and 3:7. 22 In a Chinese study, both aspirin and crude extract of Ginkgo biloba reduced superoxide anion in human coronary artery endothelial cells in a dosage-dependent manner; combinational administration of aspirin and the extract showed synergistic effects with the inhibition of reactive oxygen species production. 19 Moreover, methanol is routinely used as the solvent in the protocol of bioassay-guided fractionation of a crude phytoextract, for its capability to extract polar, moderately polar as well as nonpolar compounds from crude plant extracts holisticallyda characteristic dearth in most other organic solvents. Thus, methanol serves to a great extent the isolation of a majority of active phytocompounds of specific interest from a crude plant extract. It is anticipated that coteries of pharmacognosy, pharmacology, and pharmaceutics could take up the work on isolation and characterization of pure phytocompounds of C. albidum and their standardization as antimicrobials, singularly or in a combination as shown here. Because bacterial genomes are changing rapidly or rather dramatically to win over newer antibiotics in addition to being peripatetic, there is a fear of precipitation of future public health episodes in the unhygienic milieu of urban slum ghettos, wherein MDR bacterial pathogens insinuate and thrive well. In this condition, a combination therapy using a moribund antibiotic with a phytodrug could be cost effective. A pejorative attitude on phytodrugs would be a dislogistic approach to the plethora of natural source of drugs.
This work clearly demonstrated that nontoxic levels of methanolic extract of a nontoxic plant could have a synergistic effect along with an antibiotic, which was initially ineffective against the MDR isolates of an infamous pathogenic bacterium. Thus, similar work on using phytoextracts in rejuvenating the actions of moribund antibiotics that are unable to inhibit similar grievous pathogens could benefit clinical application of such drugs. The LC 25 value of the leaf extract was 58.88 mg/mL with human lymphocytes, and the level of 50.0 mg/mL was used in the synergistic study. The toxicity study clearly corroborated that the leaf extract was nontoxic to human lymphocyte cultures. Thus, such studies could possibly help in controlling the growth of MDR pathogens that are capable of precipitating episodes in public health. Because phytocompounds such as phlobatannins, lipids or fats, acidic compounds, and anthraquinones were absent in the leaf extract, these are supposed to have no contribution to the recorded synergistic action with CE in the control of MDR P. aeruginosa. This plant could be used as a part of integrative medicine for the pathogen, with mainstream antimicrobials, after due pharmacological checkups with test animals, despite its ethnic use as an edible crude medicine by rural and tribal people. This work is a scientific in vitro validation of a plant used by an Indian tribal society as a herbal medicine.
